Patents Assigned to Landegren Gene Technology AB
  • Patent number: 9592501
    Abstract: A microfluidic structure comprising a thermoplastic portion defining a microfluidic recess, a bonding layer on the thermoplastic portion and a siloxane elastomer portion covalently bonded to the bonding layer to seal the microfluidic recess. The microfluidic recess can therefore be formed simply, quickly and cheaply using known injection molding techniques, which are not hampered by the need for a curing step. However, the positive qualities associated with elastomers can be brought to the structure by using this to seal the microchannels. The bonding layer can be formed by silica deposited on the thermoplastic portion using techniques known in the field of optics.
    Type: Grant
    Filed: December 9, 2015
    Date of Patent: March 14, 2017
    Assignee: LANDEGREN GENE TECHNOLOGY AB
    Inventors: Jonas Sven Peter Jarvius, Jonas Melin
  • Publication number: 20090178934
    Abstract: A microfluidic structure comprising a thermoplastic portion defining a microfluidic recess, a bonding layer on the thermoplastic portion and a siloxane elastomer portion covalently bonded to the bonding layer to seal the microfluidic recess. The microfluidic recess can therefore be formed simply, quickly and cheaply using known injection molding techniques, which are not hampered by the need for a curing step. However, the positive qualities associated with elastomers can be brought to the structure by using this to seal the microchannels. The bonding layer can be formed by silica deposited on the thermoplastic portion using techniques known in the field of optics.
    Type: Application
    Filed: September 28, 2005
    Publication date: July 16, 2009
    Applicant: LANDEGREN GENE TECHNOLOGY AB
    Inventors: Jonas Sven Peter Jarvius, Jonas Melin
  • Publication number: 20050287526
    Abstract: A nucleic acid amplification method, and probes for use within the method are described.
    Type: Application
    Filed: July 12, 2002
    Publication date: December 29, 2005
    Applicants: Biocyclica AB, Landegren Gene Technology AB
    Inventors: Ulf Landegren, Mats Gullberg, Mats Nilsson